Trastuzumab deruxtecan: as the comparator
8 studies: what is tested is compared with it. Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast CancerRecruitingNCT07678957Phase 2Report a problem
- Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast CancerNot yet recruitingNCT07630103Phase 2Report a problem
- A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast CancerRecruitingNCT07497386Phase 2Report a problem
- SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized StudyNot yet recruitingNCT07417241Phase 2Report a problem
- Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast CancerNot yet recruitingNCT07416253Phase 2Report a problem
- A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)RecruitingNCT07060807Phase 3Report a problem
- Organoid-based Functional Precision Therapy for Advanced Breast CancerRecruitingNCT06102824Phase 2Report a problem
- Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast CancerActive, not recruitingNCT07371910Phase 3Report a problem